Search
CD61 (integrin-beta 3, platelet membrane glycoprotein IIIA, GPIIIA, ITGB3, GP3A)
Function:
- associates with integrin alpha-2b (CD41) in integrin alpha-2b/beta-3
Expression:
- platelets, megakaryocytes
Pathology:
- defects associated with Glanzmann thrombasthenia
- expressed in AML M7, some cases of AML M6
- AML M0 - AML M5 & most AML M6 stain negatively with antibody
Laboratory:
- HPA-1 type in blood
- HPA-4 type in blood
- HPA-6 type in blood Comparative Biology:
- in vitro & in mice, integrin alpha-V/beta-3 is a marker of breast carcinoma, lung carcinoma, & pancreatic carcinoma
- such cells have stem-like properties & are highly resistant to receptor tyrosine kinase inhibitors such as erlotinib
- in the unbound state, integrin alpha-V/beta-3 recruits KRAS & RalB to the tumor cell plasma membrane, leading to activation of TBK1 & NF-kappaB
Related
ITGB3 gene mutation
General
cluster-of-differentiation antigen; cluster designation antigen; CD antigen
glycoprotein
integrin-beta
Properties
SIZE: entity length = 788 aa
MW = 87 kD
COMPARTMENT: cellular membrane
MOTIF: signal sequence {1-26}
cysteine residue {C31}
MODIFICATION: cysteine residue {C461}
cysteine residue {C39}
MODIFICATION: cysteine residue {C49}
cysteine residue {C42}
MODIFICATION: cysteine residue {C75}
cysteine residue {C49}
MODIFICATION: cysteine residue {C39}
cysteine residue {C52}
MODIFICATION: cysteine residue {C64}
cysteine residue {C64}
MODIFICATION: cysteine residue {C52}
cysteine residue {C75}
MODIFICATION: cysteine residue {C42}
N-glycosylation site {N125}
VWFA domain {135-377}
MOTIF: cysteine residue {C203}
MODIFICATION: cysteine residue {C210}
cysteine residue {C210}
MODIFICATION: cysteine residue {C203}
cysteine residue {C258}
MODIFICATION: cysteine residue {C299}
cysteine residue {C299}
MODIFICATION: cysteine residue {C258}
N-glycosylation site {N346}
N-glycosylation site {N397}
cysteine residue {C400}
MODIFICATION: cysteine residue {C412}
cysteine residue {C412}
MODIFICATION: cysteine residue {C400}
cysteine residue {C432}
MODIFICATION: cysteine residue {C681}
cysteine residue {C459}
MODIFICATION: cysteine residue {C463}
cysteine residue {C461}
MODIFICATION: cysteine residue {C31}
Cysteine-rich tandem repeats {463-629}
MOTIF: consensus repeat {463-511}
cysteine residue {C463}
MODIFICATION: cysteine residue {C459}
cysteine residue {C474}
MODIFICATION: cysteine residue {C486}
N-glycosylation site {N478}
cysteine residue {C483}
MODIFICATION: cysteine residue {C521}
cysteine residue {C486}
MODIFICATION: cysteine residue {C474}
cysteine residue {C488}
MODIFICATION: cysteine residue {C497}
cysteine residue {C497}
MODIFICATION: cysteine residue {C488}
cysteine residue {C499}
MODIFICATION: cysteine residue {C512}
consensus repeat {512-553}
cysteine residue {C512}
MODIFICATION: cysteine residue {C499}
cysteine residue {C521}
MODIFICATION: cysteine residue {C483}
cysteine residue {C527}
MODIFICATION: cysteine residue {C532}
cysteine residue {C529}
MODIFICATION: cysteine residue {C562}
cysteine residue {C532}
MODIFICATION: cysteine residue {C527}
cysteine residue {C534}
MODIFICATION: cysteine residue {C547}
cysteine residue {C547}
MODIFICATION: cysteine residue {C534}
cysteine residue {C549}
MODIFICATION: cysteine residue {C554}
consensus repeat {554-592}
cysteine residue {C554}
MODIFICATION: cysteine residue {C549}
cysteine residue {C562}
MODIFICATION: cysteine residue {C529}
cysteine residue {C568}
MODIFICATION: cysteine residue {C573}
cysteine residue {C570}
MODIFICATION: cysteine residue {C601}
cysteine residue {C573}
MODIFICATION: cysteine residue {C568}
cysteine residue {C575}
MODIFICATION: cysteine residue {C584}
cysteine residue {C584}
MODIFICATION: cysteine residue {C575}
N-glycosylation site {N585}
cysteine residue {C586}
MODIFICATION: cysteine residue {C593}
consensus repeat {593-629}
cysteine residue {C593}
MODIFICATION: cysteine residue {C586}
cysteine residue {C601}
MODIFICATION: cysteine residue {C570}
cysteine residue {C607}
MODIFICATION: cysteine residue {C612}
cysteine residue {C609}
MODIFICATION: cysteine residue {C657}
cysteine residue {C612}
MODIFICATION: cysteine residue {C607}
cysteine residue {C614}
MODIFICATION: cysteine residue {C624}
cysteine residue {C624}
MODIFICATION: cysteine residue {C614}
cysteine residue {C627}
MODIFICATION: cysteine residue {C630}
cysteine residue {C630}
MODIFICATION: cysteine residue {C627}
cysteine residue {C634}
MODIFICATION: cysteine residue {C643}
cysteine residue {C640}
MODIFICATION: cysteine residue {C713}
cysteine residue {C643}
MODIFICATION: cysteine residue {C634}
cysteine residue {C657}
MODIFICATION: cysteine residue {C609}
cysteine residue {C661}
MODIFICATION: cysteine residue {C689}
N-glycosylation site {N680}
cysteine residue {C681}
MODIFICATION: cysteine residue {C432}
cysteine residue {C689}
MODIFICATION: cysteine residue {C661}
cysteine residue {C713}
MODIFICATION: cysteine residue {C640}
transmembrane domain {719-741}
Tyr phosphorylation site {Y773}
Thr phosphorylation site {T779}
Tyr phosphorylation site {Y785}
Database Correlations
OMIM correlations
MORBIDMAP 173470
UniProt P05106
PFAM correlations
Entrez Gene 3690
Kegg hsa:3690
References
- Molecular Cell Biology (2nd ed) Darnell J; Lodish H
& Baltimore D (eds), Scientific American Books,
WH Freeman, NY 1990, pg 921
- Clark EA & Brugge JS
Integrins and signal transduction pathways: the road taken.
Science 268:233 1995
PMID: 7716514
- http://www.pathologyoutlines.com/cdmarkers.html
15 October 2002
- Entrez Gene :accession 3690
- GeneReviews
https://www.genecards.org/cgi-bin/carddisp.pl?gene=ITGB3
- SHMPD; Note: The Singapore human mutation and polymorphism database
http://shmpd.bii.a-star.edu.sg/gene.php?genestart=A&genename=ITGB3
- UniProt :accession P05106
Component-of
integrin alpha-V/beta-3